07:52 AM EDT, 04/25/2024 (MT Newswires) -- Life sciences company Microbix Biosystems ( MBXBF ) said Thursday it will present a poster detailing results of its use of Microbix Quality Assessment Products (QAPs) to accredit clinical labs for conducting molecular tests for drug-resistant strains of M. genitalium, a common sexually-transmitted infection.

The poster will be presented at the European Congress of Clinical Microbiology and Infectious Diseases in Barcelona, Spain from April 27 to 30.